한글목차

세계의 FeNO 검사 시장의 미래는 병원과 클리닉 시장에서의 기회로 유망시되고 있습니다. 세계의 FeNO 검사 시장은 2025-2031년에 CAGR 14.1%로 성장할 것으로 예상되고 있습니다. 이 시장의 주요 촉진요인은 호흡기 질환의 유병률 증가, 조기 진단 및 맞춤형 의료에 대한 인식 증가, 대기 오염 수준 증가 등입니다.

• Lucintel의 예측에 따르면 유형별로는 천식 및 만성 호흡기 질환의 유병률 증가로 인해 일산화질소 독립형 모니터가 예측 기간 중 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 첨단 의료 인프라와 호흡기 관리 프로그램에 대한 높은 인식으로 인해 병원이 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 중 가장 높은 성장을 보일 것으로 예측됩니다.

FeNO 검사 시장의 새로운 동향

FeNO 검사 시장은 기술 발전, 헬스케어 정책, 비침습적 진단법에 대한 수요 증가로 인해 빠르게 발전하고 있습니다. 이러한 새로운 동향은 맞춤형 의료와 보다 효과적인 만성질환 관리 등 헬스케어 분야의 광범위한 변화를 반영하고 있습니다. 다음은 FeNO 검사 시장 전망를 형성하는 5가지 주요 동향입니다.

• 가정용 기기 채택 증가: 휴대용으로 사용하기 쉬운 FeNO 검사 장비가 개발되어 환자가 집에서 자신의 상태를 모니터링할 수 있게 되었습니다. 이러한 추세는 환자들에게 실시간 데이터를 제공하고 보다 개인화된 치료 계획을 가능하게 함으로써 천식 관리에 변화를 가져오고 있습니다. 가정용 기기를 통해 환자는 진료일 이외에도 자신의 상태를 파악할 수 있으며, 치료 순응도를 높이고 병원 방문을 줄일 수 있습니다. 헬스케어가 환자 중심 모델로 전환되고 있는 가운데, 이러한 장치는 개인이 호흡기 건강을 보다 효과적으로 관리할 수 있도록 하는 데 중요한 역할을 하고 있습니다.
• 디지털 헬스 플랫폼과의 통합: FeNO 검사 장비는 디지털 헬스 플랫폼과의 통합이 진행되고 있으며, 의료 서비스 프로바이더에게 원활한 데이터 전송을 가능하게 합니다. 이러한 추세는 천식 및 기타 호흡기 질환을 더 잘 모니터링할 수 있게 해주며, 실시간 데이터는 의사가 더 많은 정보에 입각한 판단을 내리는 데 도움이 됩니다. 또한 FeNO 검사와 전자건강기록(EHR) 및 원격의료 플랫폼과의 통합은 환자와 의료 전문가 간의 소통을 강화하여 환자 치료를 개선하고, 치료 계획을 적시에 조정하고 결과를 개선할 수 있도록 돕습니다.
• 장비의 소형화 및 휴대성 발전: 시장에서는 FeNO 검사 장비의 소형화, 휴대성, 사용 편의성에 대한 기술 혁신이 계속되고 있습니다. 소형화를 통해 의료 서비스 프로바이더는 이동 진료소, 원격지 등 더 많은 환경에서 이러한 장비를 사용할 수 있습니다. 이러한 추세로 인해 의료 인프라가 제한된 지역에서도 FeNO 검사를 보다 쉽게 이용할 수 있게 되었으며, 휴대용 및 소형 장비는 휴대 및 배치가 용이합니다. 휴대용 FeNO 검사는 농촌 지역이나 개발도상국에서 특히 유용합니다.
• 비침습적 진단 툴에 대한 수요 증가: FeNO 검사는 헬스케어 분야에서 비침습적 진단에 대한 광범위한 추세의 일부입니다. 환자들의 선호가 덜 침습적인 방법으로 바뀌고 있는 가운데, FeNO 검사는 채혈이나 다른 침습적 시술 없이도 기도의 염증을 측정할 수 있으며, 인기를 끌고 있습니다. 이러한 추세는 특히 빈번한 모니터링이 필요한 천식과 같은 만성질환의 관리와 관련이 있습니다. 비침습적 검사법은 환자의 편의성을 향상시키고 만성질환 관리 프로토콜의 표준이 될 것으로 예측됩니다.
• 급여 확대: FeNO 검사의 임상적 유용성이 인정됨에 따라 미국, 유럽 국가를 포함한 많은 국가에서 FeNO 검사에 대한 급여가 확대되고 있습니다. FeNO 검사가 보험 적용에 포함됨에 따라 비용 장벽이 낮아져 더 많은 사람들이 쉽게 이용할 수 있게 되었습니다. 많은 지역에서 FeNO 검사가 천식 관리를 위한 임상 지침에 포함되고 있으며, 의료 서비스 프로바이더가 종합적인 치료 계획의 일부로 FeNO 검사를 사용하도록 보장하고 있습니다. 이러한 추세는 FeNO 검사의 보급에 기여하고 있습니다.

가정용 기기, 디지털 통합, 기기 소형화, 비침습적 진단에 대한 수요, 상환 정책의 확대 등 새로운 동향은 FeNO 검사 시장을 크게 재편하고 있습니다. 이러한 추세는 FeNO 검사에 대한 접근성을 개선하고, 일상적인 의료 서비스에 대한 통합을 강화함으로써 성장을 가속하고, 궁극적으로 전 세계에서 호흡기 질환의 관리를 개선하는 데 도움이 될 것입니다.

FeNO 검사 시장의 최근 동향

FeNO 검사 시장은 기술이 더욱 발전하고 널리 채택됨에 따라 최근 여러 가지 추세를 보이고 있습니다. 이러한 발전은 제품 설계의 혁신, 호흡기 질환에 대한 인식 증가, 의료 인프라의 발전을 반영하고 있습니다. 다음은 다양한 지역의 FeNO 검사 시장을 형성하고 있는 최근 주요 동향입니다.

• 휴대용 FeNO 테스터 도입 : FeNO 검사 시장에서 가장 중요한 발전 중 하나는 휴대용 및 휴대용 FeNO 검사 장비의 출시입니다. 이 장치는 의료진이 환자의 기도 염증을 신속하게 평가할 수 있는 현장 검사를 가능하게 하고, 의료진이 환자의 기도 염증을 신속하게 평가할 수 있도록 돕습니다. 휴대용 검사기는 응급실, 클리닉, 심지어 가정에서도 천식 모니터링에 점점 더 많이 사용되고 있습니다. 이 개발은 특히 자원이 제한된 환경에서 FeNO 검사의 편의성과 접근성을 향상시킵니다.
• 원격의료와 FeNO 검사의 통합: 원격의료의 부상으로 FeNO 검사 장비는 원격의료 플랫폼에 통합되고 있습니다. 이 통합을 통해 환자는 집에서 FeNO를 측정하고 의료진과 원격으로 데이터를 공유할 수 있습니다. 이러한 추세는 지속적인 모니터링과 치료 계획을 적시에 조정할 수 있으므로 만성 호흡기 질환 환자에게 특히 유용합니다. 또한 특히 농촌 지역이나 의료 서비스가 부족한 지역의 전문 의료에 대한 접근성을 향상시킬 수 있습니다.
• 장비의 감도와 정확도 향상: 최근 발전은 FeNO 검사 장비의 감도와 정확도 향상에 초점을 맞추었습니다. 새로운 모델은 더 낮은 농도의 일산화질소를 검출할 수 있으며, 보다 정확한 측정값을 얻을 수 있으며, 기도 염증을 조기에 진단할 수 있습니다. 이러한 개선은 FeNO 검사가 천식 및 COPD 관리를 위한 신뢰할 수 있는 툴이 되어 보다 정확하고 효과적인 치료 방침을 결정하는 데 매우 중요합니다.
• 임상 가이드라인에서 FeNO 검사 확대: FeNO 검사는 전 세계에서 천식 관리 임상 가이드라인에 점점 더 많이 포함되고 있습니다. 많은 국가에서 국가 의료 시스템이 천식 진단 및 관리에서 FeNO 측정의 중요성을 인식하고 이 기술을 보급하고 있습니다. 이 개발은 의료 전문가들 사이에서 FeNO 검사의 수용성을 높이고 일상적인 임상 적용을 촉진하고 있습니다.
• 저렴한 가격의 FeNO 검사 키트 출시: 접근성을 높이기 위해 일부 제조업체는 저소득층 및 개발도상국을 대상으로 저렴한 가격의 FeNO 검사 키트를 출시하고 있습니다. 이 비용 효율적인 키트는 고가의 장비로 접근하기 어려운 지역에 대규모로 배치할 수 있는 실행 가능한 옵션을 제시합니다. 저렴한 가격의 FeNO 검사 옵션을 이용할 수 있다는 점에서 호흡기 질환이 만연하지만 의료 인프라가 제한적일 수 있는 신흥 시장에서 시장 성장이 기대됩니다.

휴대용 기기, 원격의료와의 통합, 정확도 향상, 임상 가이드라인에 포함, 저렴한 가격의 키트 등 최근 FeNO 검사의 최신 동향은 FeNO 검사의 접근성, 정확성, 통합성을 향상시키고 있습니다. 이러한 기술 혁신은 시장의 성장과 확대에 기여하고 있으며, FeNO 검사는 천식 및 호흡기 질환 관리에 필수적인 툴이 되고 있습니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 산업 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 유형별 세계의 FeNO 검사 시장

• 개요
• 유형별 매력 분석
• 일산화질소 스탠드얼론 모니터 : 동향과 예측(2019-2031년)
• 일산화질소 핸드헬드 모니터 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제5장 용도별 세계의 FeNO 검사 시장

• 개요
• 용도별 매력 분석
• 병원 : 동향과 예측(2019-2031년)
• 클리닉 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 지역의 FeNO 검사 시장

제7장 북미의 FeNO 검사 시장

• 개요
• 미국의 FeNO 검사 시장
• 멕시코의 FeNO 검사 시장
• 캐나다의 FeNO 검사 시장

제8장 유럽의 FeNO 검사 시장

• 개요
• 독일의 FeNO 검사 시장
• 프랑스의 FeNO 검사 시장
• 스페인의 FeNO 검사 시장
• 이탈리아의 FeNO 검사 시장
• 영국의 FeNO 검사 시장

제9장 아시아태평양의 FeNO 검사 시장

• 개요
• 일본의 FeNO 검사 시장
• 인도의 FeNO 검사 시장
• 중국의 FeNO 검사 시장
• 한국의 FeNO 검사 시장
• 인도네시아의 FeNO 검사 시장

제10장 기타 지역의 FeNO 검사 시장

• 개요
• 중동의 FeNO 검사 시장
• 남미의 FeNO 검사 시장
• 아프리카의 FeNO 검사 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 FeNO 검사 시장에서의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증과 라이선싱
  • 합병, 인수, 계약, 제휴, 합병사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

• 경쟁 분석
• Guangzhou Kingmed Diagnostics
• Hangzhou Clongene BIoTech
• Shanghai Fosun Long March Medical Science
• Nanjing Norman Biological Technology
• Beijing Eastwest Harmony Medical Devices
• Guangzhou Yercon Diagnostic
• Aeonmed

제14장 부록

• 도표
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel 소개
• 문의처

영문목차

The future of the global FeNO testing market looks promising with opportunities in the hospital and clinic markets. The global FeNO testing market is expected to grow with a CAGR of 14.1% from 2025 to 2031. The major drivers for this market are the rising prevalence of respiratory diseases, growing awareness of early diagnosis & personalized medicine, and the rising air pollution levels.

• Lucintel forecasts that, within the type category, nitric oxide standalone monitor is expected to witness higher growth over the forecast period due to increasing prevalence of asthma and chronic respiratory diseases.
• Within the application category, hospital is expected to witness the higher growth due to advanced healthcare infrastructure and high awareness for respiratory care programs.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the FeNO Testing Market

The FeNO testing market is evolving rapidly, driven by advancements in technology, healthcare policies, and growing demand for non-invasive diagnostic methods. These emerging trends reflect broader changes in healthcare, including personalized medicine and the push for more effective chronic disease management. Below are five key trends shaping the future of the FeNO testing market.

• Increasing Adoption of Home-Use Devices: Portable, user-friendly FeNO testing devices are being developed to allow patients to monitor their condition at home. This trend is transforming asthma management by providing patients with real-time data, enabling more personalized treatment plans. Home-use devices allow patients to track their condition outside of medical appointments, improving adherence to treatment and reducing hospital visits. As healthcare shifts towards more patient-centric models, these devices play a crucial role in empowering individuals to manage their respiratory health more effectively.
• Integration with Digital Health Platforms: FeNO testing devices are increasingly being integrated with digital health platforms, enabling seamless data transfer to healthcare providers. This trend allows for better monitoring of asthma and other respiratory conditions, with real-time data helping doctors make more informed decisions. The integration of FeNO testing with electronic health records (EHRs) and telemedicine platforms is also improving patient care by enhancing communication between patients and healthcare professionals, ensuring timely adjustments to treatment plans and improving outcomes.
• Advancements in Device Miniaturization and Portability: The market is seeing continuous innovation in making FeNO testing devices smaller, more portable, and easier to use. Miniaturization makes it possible for healthcare providers to use these devices in more settings, such as mobile clinics or remote areas. This trend is making FeNO testing more accessible in regions with limited healthcare infrastructure, where mobile or compact devices are easier to transport and deploy. Portable FeNO testing is particularly beneficial in rural areas and developing countries.
• Growing Demand for Non-Invasive Diagnostic Tools: FeNO testing is part of a broader trend towards non-invasive diagnostics in healthcare. As patient preferences shift towards less invasive methods, FeNO testing is gaining popularity because it can measure airway inflammation without requiring blood draws or other invasive procedures. This trend is particularly relevant in the management of chronic diseases like asthma, where frequent monitoring is necessary. Non-invasive testing methods improve patient comfort and are expected to become a standard part of chronic disease management protocols.
• Expansion of Reimbursement Policies: Reimbursement policies for FeNO testing are expanding in many countries, including the U.S. and European nations, as the clinical benefits of the test become more recognized. The inclusion of FeNO testing in insurance coverage helps reduce the cost barrier, making it more accessible to a broader population. In many regions, FeNO testing is being integrated into clinical guidelines for asthma management, ensuring that healthcare providers use it as part of a comprehensive treatment plan. This trend is contributing to the widespread adoption of FeNO testing.

Emerging trends such as home-use devices, digital integration, device miniaturization, demand for non-invasive diagnostics, and expanded reimbursement policies are significantly reshaping the FeNO testing market. These trends are driving growth by improving access to FeNO testing and enhancing its integration into routine healthcare practices, which will ultimately improve the management of respiratory diseases globally.

Recent Developments in the FeNO Testing Market

The FeNO testing market has seen numerous developments in recent years as the technology becomes more advanced and widely adopted. These developments reflect innovations in product design, increasing awareness of respiratory conditions, and advancements in healthcare infrastructure. The following are key recent developments that are shaping the FeNO testing market across various regions.

• Introduction of Handheld FeNO Testers: One of the most significant developments in the FeNO testing market is the launch of handheld and portable FeNO testing devices. These devices allow for point-of-care testing, making it easier for healthcare providers to assess patients' airway inflammation quickly. Handheld testers are increasingly used in emergency rooms, clinics, and even at home for monitoring asthma. This development enhances the convenience and accessibility of FeNO testing, particularly in resource-limited settings.
• Integration of FeNO Testing with Telemedicine: With the rise of telemedicine, FeNO testing devices are being integrated into telehealth platforms. This integration allows patients to take FeNO measurements at home and share the data with healthcare providers remotely. This trend is particularly beneficial for patients with chronic respiratory conditions, as it allows for continuous monitoring and timely adjustments to treatment plans. It also improves access to specialized care, particularly in rural or underserved areas.
• Improvements in Device Sensitivity and Accuracy: Recent advancements have focused on improving the sensitivity and accuracy of FeNO testing devices. New models are able to detect lower concentrations of nitric oxide, providing more accurate readings and enabling earlier diagnosis of airway inflammation. These improvements are critical in ensuring that FeNO testing is a reliable tool for asthma and COPD management, leading to more precise and effective treatment decisions.
• Expansion of FeNO Testing in Clinical Guidelines: FeNO testing is becoming increasingly integrated into clinical guidelines for asthma management worldwide. In many countries, national healthcare systems have recognized the importance of FeNO measurements in diagnosing and managing asthma, leading to more widespread use of the technology. This development is increasing the acceptance of FeNO testing among healthcare professionals and encouraging its adoption in routine clinical practice.
• Launch of Affordable FeNO Testing Kits: To increase accessibility, some manufacturers have launched affordable FeNO testing kits aimed at low-income populations or developing countries. These cost-effective kits provide a viable option for large-scale deployment in areas where expensive equipment might be unaffordable. The availability of affordable FeNO testing options is expected to drive market growth in emerging markets, where respiratory conditions are prevalent but healthcare infrastructure may be limited.

Recent developments in FeNO testing, such as handheld devices, telemedicine integration, improved accuracy, clinical guideline inclusion, and affordable kits, are enhancing the accessibility, accuracy, and integration of FeNO testing. These innovations are contributing to the growth and expansion of the market, making FeNO testing an essential tool in the management of asthma and respiratory diseases.

Strategic Growth Opportunities in the FeNO Testing Market

As the FeNO testing market continues to expand, numerous growth opportunities exist across various applications. These opportunities are driven by the increasing prevalence of asthma and other respiratory conditions, technological advancements, and the growing demand for personalized healthcare. Below are five key strategic growth opportunities by application that can propel the FeNO testing market forward.

• Growth in Point-of-Care Testing: Point-of-care testing is a significant growth opportunity for the FeNO testing market. The increasing demand for faster diagnostics in emergency rooms, clinics, and even in home settings is driving the adoption of portable FeNO testing devices. Point-of-care testing enables immediate assessment of airway inflammation, improving decision-making for asthma management and treatment. As healthcare systems move toward more accessible, patient-centered care, the demand for point-of-care FeNO testing solutions will continue to grow.
• Expansion in Telemedicine Applications: Telemedicine offers a key growth opportunity for the FeNO testing market, particularly as more healthcare providers embrace remote patient monitoring. FeNO testing devices integrated into telehealth platforms allow for continuous asthma management, offering patients the convenience of monitoring their condition at home. This trend is especially valuable in rural areas or regions with limited access to healthcare specialists, making FeNO testing more accessible and effective in managing chronic respiratory conditions.
• Increasing Use in Clinical Research: FeNO testing is increasingly being used in clinical research to study the effects of different asthma treatments and interventions. Researchers are adopting FeNO measurements to monitor inflammation and treatment response, making it a valuable tool for drug development and clinical trials. This growing use of FeNO testing in research provides opportunities for manufacturers to expand their market presence and target the pharmaceutical and clinical research sectors.
• Focus on Emerging Markets: Emerging markets, particularly in regions such as Asia-Pacific and Latin America, present significant growth opportunities for the FeNO testing market. The rising prevalence of asthma and other respiratory diseases in these regions, coupled with improvements in healthcare infrastructure, is increasing demand for advanced diagnostic tools like FeNO testing. Expanding into these markets with cost-effective and portable solutions can drive market growth and improve access to high-quality asthma management in underserved regions.
• Development of Personalized Medicine Applications: As personalized medicine becomes more prevalent, there is an increasing opportunity for FeNO testing to play a pivotal role in individualized treatment plans for asthma and COPD patients. By measuring airway inflammation in real-time, FeNO testing provides critical information that helps tailor treatments based on the patient's specific needs. The integration of FeNO testing into personalized medicine frameworks will drive its adoption and further establish its importance in chronic disease management.

Strategic growth opportunities in point-of-care testing, telemedicine, clinical research, emerging markets, and personalized medicine are driving the FeNO testing market forward. These opportunities are broadening the scope of FeNO testing and making it more accessible, efficient, and effective in managing asthma and respiratory diseases.

FeNO Testing Market Driver and Challenges

The FeNO testing market is influenced by a range of drivers and challenges, including technological advances, regulatory changes, and economic factors. These elements shape the growth trajectory and adoption of FeNO testing across different regions and applications. Below are five key drivers and three main challenges impacting the market, providing a comprehensive overview of the factors at play.

The factors responsible for driving the FeNO testing market include:

1. Increasing Prevalence of Respiratory Diseases: The rising global incidence of asthma and COPD is a major driver for the FeNO testing market. As the number of patients with these conditions increases, the demand for effective and non-invasive diagnostic tools like FeNO testing grows. FeNO testing helps in early detection and personalized treatment, making it an essential tool in managing respiratory diseases.

2. Technological Advancements in FeNO Testing Devices: Recent innovations in FeNO testing devices, including portable, handheld models and improved sensitivity, are driving market growth. These advancements make FeNO testing more accessible and accurate, allowing for wider adoption in both clinical and home settings. The continuous improvement of FeNO testing technology is enhancing the device's usability and increasing its clinical relevance.

3. Government Initiatives and Support for Respiratory Health: Governments around the world are investing in better healthcare infrastructure and promoting disease prevention programs, especially for chronic diseases like asthma. These initiatives support the adoption of FeNO testing as a valuable tool for early diagnosis and management. Policies that expand reimbursement for FeNO testing also boost market growth by making the technology more affordable and accessible.

4. Rising Demand for Personalized Healthcare: The shift towards personalized medicine, where treatments are tailored to individual patient needs, is driving demand for tools like FeNO testing. By measuring inflammation in the airways, FeNO testing helps healthcare providers personalize asthma management plans, ensuring better treatment outcomes. This growing trend toward individualized care is a strong driver for the market.

5. Expanding Healthcare Access in Emerging Markets: As healthcare access improves in emerging markets, the demand for advanced diagnostic tools like FeNO testing increases. The availability of portable and cost-effective FeNO testing devices is facilitating market growth in regions like Asia-Pacific, where the prevalence of asthma is on the rise. Expanding access to FeNO testing in these regions is a key driver for the market.

Challenges in the FeNO testing market are:

1. High Costs of FeNO Testing Devices: Despite the benefits of FeNO testing, the high cost of devices and related testing can be a barrier to adoption, particularly in low-income regions. While prices are decreasing with technological advancements, affordability remains a challenge for broader market penetration.

2. Regulatory Hurdles and Approval Delays: The approval process for medical devices, including FeNO testing equipment, can be lengthy and complex, with varying regulatory standards across regions. These hurdles may slow the introduction of new devices to the market and impact the speed of innovation, limiting the potential for rapid market growth.

3. Lack of Awareness and Training: In some regions, healthcare providers may lack awareness of FeNO testing or may not be trained in its use. This can lead to underutilization of the technology, particularly in emerging markets. Education and training programs are needed to ensure that healthcare providers can effectively integrate FeNO testing into their practice.

The FeNO testing market is being shaped by drivers such as the increasing prevalence of respiratory diseases, technological advancements, government support, demand for personalized healthcare, and expanded access in emerging markets. However, challenges like high device costs, regulatory delays, and a lack of awareness must be addressed to unlock the full potential of the market.

List of FeNO Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies FeNO testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the FeNO testing companies profiled in this report include-

• Guangzhou Kingmed Diagnostics
• Hangzhou Clongene Biotech
• Shanghai Fosun Long March Medical Science
• Nanjing Norman Biological Technology
• Beijing Eastwest Harmony Medical Devices
• Guangzhou Yercon Diagnostic
• Aeonmed

FeNO Testing Market by Segment

The study includes a forecast for the global FeNO testing market by type, application, and region.

FeNO Testing Market by Type [Value from 2019 to 2031]:

• Nitric Oxide Standalone Monitor
• Nitric Oxide Handheld Monitor
• Others

FeNO Testing Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Others

FeNO Testing Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the FeNO Testing Market

The FeNO (Fractional exhaled Nitric Oxide) testing market has experienced significant growth due to its role in the diagnosis and management of respiratory conditions like asthma. This non-invasive method helps measure airway inflammation, offering a critical tool for clinicians in assessing asthma severity and treatment effectiveness. As healthcare systems evolve and patient care becomes more personalized, the adoption of FeNO testing is increasing globally. Below, we highlight recent developments in FeNO testing across key markets such as the United States, China, Germany, India, and Japan, showcasing innovations, regulatory changes, and growing adoption.

• United States: In the U.S., FeNO testing is gaining popularity as a standard tool for managing asthma and chronic obstructive pulmonary disease (COPD). The increased focus on precision medicine and personalized healthcare has fueled the demand for more accurate and non-invasive diagnostic tools. Recent advancements in FeNO testing devices, such as portable and handheld devices, have improved accessibility and patient compliance. Additionally, healthcare providers are increasingly incorporating FeNO measurements alongside traditional tests for better asthma control. Medicare and private insurers have expanded reimbursement policies for FeNO testing, facilitating its wider adoption in clinical practices across the country.
• China: China has seen a rising adoption of FeNO testing due to the country's growing healthcare demands, particularly in urban areas. With an increasing prevalence of asthma and other respiratory diseases, Chinese healthcare providers are turning to FeNO testing as an effective diagnostic tool. The market is also benefiting from government efforts to enhance healthcare infrastructure and improve chronic disease management. Local manufacturers are developing cost-effective FeNO testing devices tailored to meet the needs of a broader population, which is helping to make the technology more accessible. Awareness campaigns and improvements in the overall healthcare system are driving market growth.
• Germany: Germany's healthcare system is well-established, and the country has seen steady adoption of FeNO testing within clinical and research settings. In line with broader European healthcare trends, Germany has been focusing on improving early diagnosis and personalized treatment plans for asthma and other respiratory conditions. The country's regulatory environment supports the use of FeNO testing, with strong integration into clinical guidelines for asthma management. Moreover, German medical device manufacturers are advancing FeNO testing technologies, incorporating features such as wireless connectivity for data sharing and integration with electronic health records, enhancing overall patient care.
• India: In India, FeNO testing is still emerging but gaining momentum, particularly in larger cities with better healthcare infrastructure. The increasing awareness of asthma, along with the rising prevalence of air pollution-related respiratory conditions, has highlighted the need for advanced diagnostic tools. However, the adoption of FeNO testing is hampered by cost-related concerns, though the growing availability of affordable, portable devices is expected to increase adoption. Local healthcare initiatives are also working to improve access to non-invasive diagnostic tools for asthma and COPD, which could drive further growth in the FeNO testing market in the coming years.
• Japan: Japan has been a leader in adopting advanced diagnostic tools, and FeNO testing is becoming more integrated into the management of respiratory conditions, especially in asthma. The country is focusing on advancing precision medicine and improving the monitoring of chronic diseases through non-invasive technologies. FeNO testing is included in national guidelines for asthma management, increasing its usage among healthcare professionals. The Japanese market is seeing innovations in FeNO measurement devices, including improved sensitivity and the development of home-use testing kits, offering more convenient and patient-friendly options for asthma monitoring and management.

Features of the Global FeNO Testing Market

• Market Size Estimates: FeNO testing market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: FeNO testing market size by type, application, and region in terms of value ($B).
• Regional Analysis: FeNO testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the FeNO testing market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the FeNO testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the FeNO testing market by type (nitric oxide standalone monitor, nitric oxide handheld monitor, and others), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global FeNO Testing Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Nitric Oxide Standalone Monitor: Trends and Forecast (2019-2031)
• 4.4 Nitric Oxide Handheld Monitor: Trends and Forecast (2019-2031)
• 4.5 Others: Trends and Forecast (2019-2031)

5. Global FeNO Testing Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Clinic: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global FeNO Testing Market by Region

7. North American FeNO Testing Market

• 7.1 Overview
• 7.4 United States FeNO Testing Market
• 7.5 Mexican FeNO Testing Market
• 7.6 Canadian FeNO Testing Market

8. European FeNO Testing Market

• 8.1 Overview
• 8.4 German FeNO Testing Market
• 8.5 French FeNO Testing Market
• 8.6 Spanish FeNO Testing Market
• 8.7 Italian FeNO Testing Market
• 8.8 United Kingdom FeNO Testing Market

9. APAC FeNO Testing Market

• 9.1 Overview
• 9.4 Japanese FeNO Testing Market
• 9.5 Indian FeNO Testing Market
• 9.6 Chinese FeNO Testing Market
• 9.7 South Korean FeNO Testing Market
• 9.8 Indonesian FeNO Testing Market

10. ROW FeNO Testing Market

• 10.1 Overview
• 10.4 Middle Eastern FeNO Testing Market
• 10.5 South American FeNO Testing Market
• 10.6 African FeNO Testing Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global FeNO Testing Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Guangzhou Kingmed Diagnostics
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Hangzhou Clongene Biotech
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Shanghai Fosun Long March Medical Science
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Nanjing Norman Biological Technology
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Beijing Eastwest Harmony Medical Devices
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Guangzhou Yercon Diagnostic
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Aeonmed
  • Company Overview
  • FeNO Testing Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us